PPARG and ulcerative colitis: Since PPARγ is decreased in IBDs such as ulcerative colitis and Crohn’s disease and it has been shown that Se can increase both PPARγ and its ligand 15d-PGJ2 [5,13], it is plausible that under supplemented Se status, the disease would be significantly decreased.